Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-60 of 8327

Edit search filters
  1. A Study to Evaluate Filter Comparison for Reducing COVID-19 Infection Risk

    Rochester, MN

  2. Evaluation of the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita® System in Subjects With Type 2 Diabetes on Insulin Therapy

    Scottsdale/Phoenix, AZ

  3. Test-retest Comparison of the Lower Quarter Y-Balance Test

    Rochester, MN

  4. Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects with Neuroendocrine Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. Integrated Tele-monitoring and Patient-centric Health Coaching Strategy in Patients Hospitalized With Heart Failure

    La Crosse, WI, Eau Claire, WI, Jacksonville, FL

  6. Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical

    Rochester, MN

  7. Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated EVLP Facility

    Jacksonville, FL

  8. Resistance Training in HFpEF

    Rochester, MN

  9. Primary Hyperoxaluria Mutation Genotyping/Phenotyping

    Rochester, MN

  10. Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

    Rochester, MN

.

Mayo Clinic Footer